ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
68,896.44
0.53%
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs Yen
156.965
0.00%
Brent Oil
81.965
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Hollis-Eden Pharmaceuticals (MM) (HEPH)

  7. Hollis-Eden Pharmaceuticals (MM) (HEPH) ニュース

HEPH

Hollis-Eden Pharmaceuticals (MM) (HEPH)

Hollis-Eden Pharmaceuticals (MM)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:HEPH
日付受信時刻ニュースソース見出しコード企業名
2010/02/1806 : 03PR Newswire (US)Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to 'HRBR'NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2010/02/1706 : 27Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2010/02/0404 : 39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2010/02/0404 : 38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2010/02/0404 : 37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2010/02/0404 : 37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2010/02/0404 : 36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2010/02/0404 : 35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2010/02/0404 : 35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2010/01/0706 : 31Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3/A)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/12/2306 : 38Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/12/1520 : 03Edgar (US Regulatory)Securities Registration (section 12(b)) (8-A12B)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/11/1623 : 00PR Newswire (US)Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies of Apoptone (HE3235) at AACR Molecular TaNASDAQ:HEPH
2009/11/1306 : 37PR Newswire (US)Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and CancerNASDAQ:HEPH
2009/11/0707 : 23Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/10/2219 : 05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/10/2022 : 11PR Newswire (US)Hollis-Eden Pharmaceuticals Retains Burrill LLC to Provide Exclusive Advisory Services for Lead ProgramsNASDAQ:HEPH
2009/09/1702 : 33Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/09/1621 : 30PR Newswire (US)Hollis-Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid PriceNASDAQ:HEPH
2009/08/1419 : 06Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/06/1604 : 52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/06/1601 : 30Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/06/1520 : 05PR Newswire (US)Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEONASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/06/1205 : 54Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/06/0605 : 06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/05/1419 : 03Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/05/0806 : 00Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/04/2406 : 00Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/04/0106 : 36Business WireHollis-Eden Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial ResultsNASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
2009/04/0106 : 30Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:HEPH

最近閲覧した銘柄

AMEX
XLF
Financial Select Sector
USOTC
ADDYY
Adidas (QX)
AMEX
XLV
Health Care Select Sector
FX
USDJPY
US Dollar vs Yen
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
SOLUSD
Solana
AMEX
XLE
Energy Select Sector SPDR
CCOM
US500
US 500
NASDAQ
TSLA
Tesla
NASDAQ
MSFT
Microsoft
FX
USDEUR
US Dollar vs Euro
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US100
US Tech 100
NYSE
JPM
JP Morgan Chase
NASDAQ
AAPL
Apple
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有